Licensing Red/ET recombination

Gene Bridges GmbH owns the exclusive rights to Red/ET recombination and issues licenses for the use of the Red/ET Recombination technology to commercial users. Licensing arrangements for Red/ET recombination are provided as world-wide, non-exclusive sub-licenses.


Full commercial license (standard format)

Gene Bridges can customize full licenses to include access to any combination of the following applications:

  • cloning & subcloning

  • knock-out & knock-in constructs

  • transgenic constructs

  • conditional knock-outs

  • viral engineering

  • transgenic plants

  • strain modification & optimisation

They can be tailored to fit your requirements!

Full license_Eukaryotic applications.pdf
Full license_Prokaryotic applications.pdf


For more information please contact licenses@genebridges.com

To the top

Please choose your country. If the country is missing, continue.

Shanghai QF Biosciences
Shanghai QF Biosciences
NeuProCell
Biotech Desk
NeuProCell
Biotech Desk
BioTag
BioTag
Funakoshi
Funakoshi
Mbiotech
Mbiotech
iDNA
iDNA
iDNA
iDNA
iDNA
iDNA
iDNA
iDNA
Gendiscovery
Gendiscovery
BioCat
BioCat
BioCat
BioCat
BioCat
BioCat
Biovalley
Biovalley
Quimigen
Quimigen
Brunschwig Chemie
Brunschwig Chemie
Cambio
Cambio
Cambio
Cambio
Immuno Diagnostic
Immuno Diagnostic
Immuno Diagnostic
Immuno Diagnostic
Immuno Diagnostic
Immuno Diagnostic
Immuno Diagnostic
Immuno Diagnostic
Immuno Diagnostic
Nanodiagnostika
Immuno Diagnostic
Nanodiagnostika
Nanodiagnostika
Nanodiagnostika
Nanodiagnostika
Nanodiagnostika
AS ONE INTERNATIONAL, INC.
AS ONE INTERNATIONAL, INC.
Valquim
Valquim